BG
NTUS

Bollard Group’s Natus Medical Inc NTUS Stock Holding History

Bollard Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-790
Closed -$21K – 435
2022
Q1 		$21K Hold
790
– – ﹤0.01% 386
2021
Q4 		$19K Hold
790
– – ﹤0.01% 393
2021
Q3 		$20K Hold
790
– – ﹤0.01% 390
2021
Q2 		$21K Hold
790
– – ﹤0.01% 392
2021
Q1 		$20K Hold
790
– – ﹤0.01% 395
2020
Q4 		$16K Hold
790
– – ﹤0.01% 396
2020
Q3 		$14K Sell
790
-550
-41% -$10.4K ﹤0.01% 400
2020
Q2 		$29K Buy
+1,340
New +$30.7K ﹤0.01% 392

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group's NTUS Position: Q2 2022 in Review

Bollard Group sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 790 shares — an estimated $21K sold.

Bollard Group first reported a position in NTUS in Q2 2020 and held it in 8 quarters. The position peaked at $29K in Q2 2020. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Bollard Group reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Bollard Group sold 790 Natus Medical Inc shares in Q2 2022, an estimated $21K.
  • Bollard Group first reported a position in Natus Medical Inc in Q2 2020 and held it in 8 quarters.
  • Bollard Group's Natus Medical Inc position peaked at $29K in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.